Driehaus Micro Cap Growth DMCRX

Medalist Rating as of | See Driehaus Investment Hub
  • NAV / 1-Day Return 13.68  /  +0.51 %
  • Total Assets 300.3 Mil
  • Adj. Expense Ratio
    1.410%
  • Expense Ratio 1.410%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Small Growth
  • Investment Style Small Growth
  • Min. Initial Investment 10,000
  • Status Limited
  • TTM Yield 0.73%
  • Turnover 128%

USD | NAV as of Sep 28, 2024 | 1-Day Return as of Sep 28, 2024, 12:12 AM GMT+0

Morningstar’s Analysis DMCRX

Will DMCRX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Driehaus Micro Cap Growth's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DMCRX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 19.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Northern Institutional US Govt Sel

3.30 9.3 Mil
Cash and Equivalents

Crinetics Pharmaceuticals Inc

3.16 8.9 Mil
Healthcare

Modine Manufacturing Co

2.49 7.0 Mil
Consumer Cyclical

TransMedics Group Inc

2.35 6.6 Mil
Healthcare

Rhythm Pharmaceuticals Inc

1.85 5.2 Mil
Healthcare

Xenon Pharmaceuticals Inc

1.81 5.1 Mil
Healthcare

Arlo Technologies Inc

1.76 4.9 Mil
Industrials

Alkami Technology Inc

1.71 4.8 Mil
Technology

EverQuote Inc Class A

1.61 4.5 Mil
Communication Services

Veeco Instruments Inc

1.59 4.5 Mil
Technology

Sponsor Center